CRDF Earnings Forecast
Looking ahead, CRDF remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 105.56K and an EPS of -0.19.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 6.56%, while EPS estimates have been Revise Downward by -7.92%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -12.5% . These revisions correlate with a 39.37% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in CRDF long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Revenue Estimates for FY2025
Revise Upward
+6.56%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-7.92%
In Past 3 Month
Unlock the reason behind revisions!
Revenue Estimates for Q4 2025
Revise Downward
-12.5%
In Past 3 Month
Stock Price
Go Up
+39.37%
In Past 3 Month
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how CRDF performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CRDF sees a -2.80% change in stock price 10 days leading up to the earnings, and a +17.04% change 10 days following the report. On the earnings day itself, the stock moves by +0.14%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -2.67% on the day following the earnings release and then changed by -12.89% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of CRDF's latest earnings report for FY2025Q3?
CRDF reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 120.00K against an estimate of 121.43K, resulting in a -1.18% surprise. The EPS was 0, surpassing the expected -0.2 by 0% . The stock experienced a 0.45% price change on the earnings day and a 2.23% change over the next five days, reflecting market reactions to the results.
How did CRDF's stock price react after the FY2025Q3 earnings release?
Following CRDF's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by 0.45% on the day of the release. Over the subsequent five days, it saw a 2.23% change. Historically, CRDF's stock price tends to shift by an average of -2.80% in the 10 days leading up to earnings and +17.04% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for CRDF for 2025/Q4?
For 2025/Q4, analysts estimate CRDF’s annual revenue to reach 105.56K, while the EPS is projected at -0.19. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 6.56% and EPS estimates Revise Downward by -12.5% over the past three months, indicating analyst expectation in the company’s performance.
How does CRDF's stock price correlate with earnings forecast revisions?
The correlation between CRDF's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 6.56%, while EPS estimates moved Revise Downward by -12.5% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from CRDF's next earnings report?
Based on historical trends, CRDF's stock price typically moves by -2.80% in the 10 days before its earnings and +17.04% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.19 and revenue of 105.56K.
What is the sentiment in Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Call Summary?
The earnings call presents a balanced picture. Financially, the company shows a solid cash position and runway, but faces risks from regulatory changes and market competition. The Q&A reveals positive clinical progress but lacks clarity on timelines, which could concern investors. The $40 million capital raise is a positive, but the absence of specific guidance and potential delays in trials offset this. Overall, the sentiment is neutral as positives are balanced by uncertainties and risks.